NCT03293251

Brief Summary

  1. 1.determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not.
  2. 2.Success rates of trabeculectomy with MMC in Queen Elizabeth hospital.
  3. 3.recurrence rate of uveitis after glaucoma surgery

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 26, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 29, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2018

Completed
Last Updated

September 26, 2017

Status Verified

September 1, 2017

Enrollment Period

1.2 years

First QC Date

September 20, 2017

Last Update Submit

September 24, 2017

Conditions

Outcomes of Trabeculectomy With MMC

Outcome Measures

Primary Outcomes (1)

  • Success rates

    IOP less 21 mmHg

    5 year period

Study Arms (2)

uveitic/ POAG

Outcomes, success rates, complications of trabeculectomy with MMC in Uveitic glaucoma

Procedure: Trabeculectomy with MMC

POAG

Outcomes, success rates, complications of trabeculectomy with MMC and I stent in this groups

Procedure: Trabeculectomy with MMC

Interventions

Trabeculectomy with MMCPROCEDURE

glaucoma surgeries

Also known as: I-STENT
POAGuveitic/ POAG

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cohort of patient documented on the database system of Queen Elizabeth hospital

You may qualify if:

  • Fesh trabeculectomy surgeries

You may not qualify if:

  • recurrent surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maha Said

Egypt, Asyut Governorate, Egypt

Location

MeSH Terms

Interventions

Trabeculectomy

Intervention Hierarchy (Ancestors)

Filtering SurgeryOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Dr Kamel Soliman, professor

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

September 20, 2017

First Posted

September 26, 2017

Study Start

August 1, 2017

Primary Completion

October 29, 2018

Study Completion

December 29, 2018

Last Updated

September 26, 2017

Record last verified: 2017-09

Locations

EG(1)